Tensive publishes positive long-term clinical follow-up data in Breast Cancer on REGENERA / SOFTAG breast implant
24-month Phase I follow-up data show positive outcomes are maintained High levels of…
Tensive appointsmedical device veteran Bill Hunter Chairman as its bioresorbable scaffold for breast reconstruction after cancer approaches market
Has more than 30 years of experience bringing innovations to market, including…
